Literature DB >> 16054188

Antigen-specific and non-specific CD4+ T cell recruitment and proliferation during influenza infection.

Timothy J Chapman1, Maria R Castrucci, Ryan C Padrick, Linda M Bradley, David J Topham.   

Abstract

To track epitope-specific CD4(+) T cells at a single-cell level during influenza infection, the MHC class II-restricted OVA(323-339) epitope was engineered into the neuraminidase stalk of influenza/A/WSN, creating a surrogate viral antigen. The recombinant virus, influenza A/WSN/OVA(II), replicated well, was cleared normally, and stimulated both wild-type and DO11.10 or OT-II TCR transgenic OVA-specific CD4(+) T cells. OVA-specific CD4 T cells proliferated during infection only when the OVA epitope was present. However, previously primed (but not naive) transgenic CD4(+) T cells were recruited to the infected lung both in the presence and absence of the OVA(323-339) epitope. These data show that, when primed, CD4(+) T cells may traffic to the lung in the absence of antigen, but do not proliferate. These results also document a useful tool for the study of CD4 T cells in influenza infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054188     DOI: 10.1016/j.virol.2005.06.023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  44 in total

1.  The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?

Authors:  Sesquile Ramon; Steven F Baker; Julie M Sahler; Nina Kim; Eric A Feldsott; Charles N Serhan; Luis Martínez-Sobrido; David J Topham; Richard P Phipps
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection.

Authors:  Hailong Guo; David J Topham
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

3.  Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors.

Authors:  Hulin Wu; Arun Kumar; Hongyu Miao; Jeanne Holden-Wiltse; Timothy R Mosmann; Alexandra M Livingstone; Gabrielle T Belz; Alan S Perelson; Martin S Zand; David J Topham
Journal:  J Immunol       Date:  2011-09-23       Impact factor: 5.422

4.  Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated Foxp3+ regulatory T cell response.

Authors:  Richard J Betts; Nayana Prabhu; Adrian W S Ho; Fei Chuin Lew; Paul E Hutchinson; Olaf Rotzschke; Paul A Macary; D Michael Kemeny
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

5.  Kupffer cell-dependent hepatitis occurs during influenza infection.

Authors:  Noelle K Polakos; Judith C Cornejo; Debbie A Murray; Kate O Wright; John J Treanor; I Nicholas Crispe; David J Topham; Robert H Pierce
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

6.  Identification of a unique population of tissue-memory CD4+ T cells in the airways after influenza infection that is dependent on the integrin VLA-1.

Authors:  Timothy J Chapman; David J Topham
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

7.  T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model.

Authors:  Hailong Guo; Félix Santiago; Kris Lambert; Toru Takimoto; David J Topham
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

8.  Differential mucosal IL-10-induced immunoregulation of innate immune responses occurs in influenza infected infants/toddlers and adults.

Authors:  David Verhoeven; Sheldon Perry
Journal:  Immunol Cell Biol       Date:  2016-09-15       Impact factor: 5.126

9.  A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation.

Authors:  Matthew A Schaller; Lara E Kallal; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

10.  Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity.

Authors:  Jae-Kwang Yoo; Carole L Galligan; Carl Virtanen; Eleanor N Fish
Journal:  J Exp Med       Date:  2010-06-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.